- Editor's Introduction to This Issue (G&I 15:2, 2017)
-
Chung YJ
- KMID: 2384031
- Genomics Inform.
- 2017 Jun;15(2):55-55.
- doi: 10.5808/GI.2017.15.2.55
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- In Silico Signature Prediction Modeling in Cytolethal Distending Toxin-Producing Escherichia coli Strains
-
Javadi M, Oloomi M, Bouzari S
- KMID: 2384034
- Genomics Inform.
- 2017 Jun;15(2):69-80.
- doi: 10.5808/GI.2017.15.2.69
In this study, cytolethal distending toxin (CDT) producer isolates genome were compared with genome of pathogenic and commensal Escherichia coli strains. Conserved genomic signatures among different types of CDT producer... -
- CITED
-
- Close
- SHARE
-
- Close
- A Variant in RUNX3 Is Associated with the Risk of Ankylosing Spondylitis in Koreans
-
Cho SM, Jung SH, Chung YJ
- KMID: 2384033
- Genomics Inform.
- 2017 Jun;15(2):65-68.
- doi: 10.5808/GI.2017.15.2.65
Ankylosing spondylitis (AS) is a chronic autoinflammatory disease that affects the spine and sacroiliac joints. Regarding its etiology, although HLA-B27 is known to be the strongest genetic factor of AS,... -
- CITED
-
- Close
- SHARE
-
- Close
- Analysis of Gene Expression in Human Dermal Fibroblasts Treated with Senescence-Modulating COX Inhibitors
-
Han JA, Kim JI
- KMID: 2384032
- Genomics Inform.
- 2017 Jun;15(2):56-64.
- doi: 10.5808/GI.2017.15.2.56
We have previously reported that NS-398, a cyclooxygenase-2 (COX-2)–selective inhibitor, inhibited replicative cellular senescence in human dermal fibroblasts and skin aging in hairless mice. In contrast, celecoxib, another COX-2–selective inhibitor,... -
- CITED
-
- Close
- SHARE
-
- Close
